DBV Technologies (DBVT) Share-based Compensation (2020 - 2026)

DBV Technologies (DBVT) reported Share-based Compensation of $2.3 million for Q1 2026, up 35.29% year-over-year from $1.7 million in Q1 2025, and up 19.54% quarter-over-quarter from $1.9 million in Q4 2025.

DBV Technologies (DBVT) Share-based Compensation (2020 - 2026) Analysis & Trends

DBV Technologies (DBVT) has 7 years of Share-based Compensation data on file, last reported at $2.3 million in Q1 2026.

  • Share-based Compensation for Q1 2026 came in at $2.3 million, up 35.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 million (up 37.25% YoY), and the FY2025 annual result was $5.4 million, up 16.6% from the prior year.
  • Share-based Compensation grew to $2.3 million in Q1 2026 per DBVT's latest filing, from $1.9 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $2.3 million in Q1 2026 and troughed at -$453000.0 in Q4 2024.
  • A 5-year average of $1.4 million and a median of $1.5 million in 2024 frame the typical range for Share-based Compensation.
  • The sharpest annual moves came in 2024 and 2025: Share-based Compensation sank 137.16% in 2024, then soared 524.72% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $1.6 million in 2022, then retreated by 24.29% to $1.2 million in 2023, then plunged by 137.16% to -$453000.0 in 2024, then soared by 524.72% to $1.9 million in 2025, then rose by 19.54% to $2.3 million in 2026.
  • Business Quant data shows DBVT's Share-based Compensation at $2.3 million in Q1 2026, $1.9 million in Q4 2025, and $516000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn 2.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.30 Mn
Mar 31, 2026 2.30 Mn
Dec 31, 2025 1.92 Mn
Dec 31, 2025 1.92 Mn
Sep 30, 2025 516,000.00
Sep 30, 2025 516,000.00
Jun 30, 2025 1.25 Mn
Jun 30, 2025 1.25 Mn
Mar 31, 2025 1.70 Mn
Mar 31, 2025 1.70 Mn
Dec 31, 2024 -453,000.00
Dec 31, 2024 -453,000.00
Sep 30, 2024 1.59 Mn
Sep 30, 2024 1.59 Mn
Jun 30, 2024 1.53 Mn
Jun 30, 2024 1.53 Mn
Mar 31, 2024 1.96 Mn
Mar 31, 2024 1.96 Mn
Dec 31, 2023 1.22 Mn
Dec 31, 2023 1.22 Mn